Inspira Technologies Expands U.S. Commercial Footprint with New Deployment at Top-Ranked New York Academic Medical Center.

Wednesday, Feb 18, 2026 8:35 am ET1min read
IINN--

Inspira Technologies has expanded its US commercial footprint by deploying its FDA-cleared INSPIRA ART100 system at a new academic medical center in New York, ranked among the top 10 in New York State. The deployment is part of a structured commercial evaluation to define clinical protocols and potential broader institutional adoption. This marks a continued execution of the company's US commercial strategy and demonstrates the ART100's suitability for top-tier US healthcare providers.

Inspira Technologies Expands U.S. Commercial Footprint with New Deployment at Top-Ranked New York Academic Medical Center.

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet